Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease

Clinical trial NCT02491359 · COMPLETED

Trial details

NCT number: NCT02491359
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft Versus Host Disease

Start date: 2015-11-12
Primary completion: 2018-02-19
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.